• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ultragenyx Pharmaceutical Inc. - Common Stock (NQ:RARE)

    22.72 +0.89 (+4.08%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Ultragenyx Pharmaceutical Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline
    Did you buy RARE common stock between August 3, 2023, and December 26, 2025? 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Ultragenyx Pharmaceutical Inc. (RARE) Class Action Lawsuit: Investors Face April 6, 2026, Deadline
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Ultragenyx Pharmaceutical Inc.
    Via GlobeNewswire
    News headline image
    RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    NASDAQ: RARE: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc.
    Did you buy RARE common stock between August 3, 2023, and December 26, 2025? 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    NASDAQ: RARE: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc.
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    RARE INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Stockholders Who Lost Money Investing in Ultragenyx Pharmaceutical Inc. Should Contact Robbins LLP for Information About Recovering Their Losses from RARE
    From Robbins LLP
    Via GlobeNewswire
    News headline image
    CLASS ACTION ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges RARE Investors With Losses to Contact the Firm
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges RARE Investors With Losses to Contact the Firm
    Did you buy RARE common stock between August 3, 2023, and December 26, 2025? 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    Did you buy RARE common stock between August 3, 2023, and December 26, 2025? 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    RARE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    RARE Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc. (RARE)
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    RARE Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc. (RARE)
    Did you buy RARE common stock between August 3, 2023, and December 26, 2025? 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    News headline image
    RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Class Action Announcement RARE: A Securities Fraud Class Action Lawsuit Was Filed Against Ultragenyx Pharmaceutical Inc. (RARE)
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Class Action Announcement RARE: A Securities Fraud Class Action Lawsuit Was Filed Against Ultragenyx Pharmaceutical Inc. (RARE)
    Did you buy RARE common stock between August 3, 2023, and December 26, 2025? 
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Ultragenyx Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
    From Ultragenyx Pharmaceutical Inc.
    Via GlobeNewswire
    News headline image
    Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    RARE Investors: Kessler Topaz Meltzer & Check, LLP Reminds Investors of April 6, 2026 Deadline in Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.
    From Kessler Topaz Meltzer & Check, LLP
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.